Final rule on CRADA amendment
This article was originally published in The Gray Sheet
Executive SummaryNonprofits and small businesses should negotiate with collaborating parties over patent rights, but "in the absence of an agreement, [a new federal provision] provides certain minimum rights for the collaborating party in inventions made by the contractor or grantee," the Commerce Department states in a final rule amending conditions for government Cooperative Research & Development Agreements. The rule goes into effect May 3...
You may also be interested in...
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.